News & Events

Instinctif Partners’ Sue Charles Standing for Election for BioIndustry Association Board

Instinctif Partners’ Sue Charles Standing for Election for BioIndustry Association Board

18 September 2017, London, UK:  Instinctif Partners is pleased to announce that Sue Charles, Managing Partner of its Life Sciences Practice and 30 year veteran of the biotech industry is standing for election for the BioIndustry Association (BIA) Board of Directors.

There are a total of 11 candidates standing for election: seven are up for the four board positions for Corporate Members; and four candidates for the one board position for the ‘Other’ Members category (being Associate Members and Network members).  Profiles of candidates can be found HERE.

Voting is now open until 9 October 2017 via the following link: or by return of ballot papers by email to or by post to The Company Secretary, BioIndustry Association, 7th Floor, Southside, 105 Victoria Street, London, SW1E 6QT no later than 5.00 pm on 10 October 2017. Voting is limited to one vote per member.

Sue Charles said “As an active supporter of the BIA over many years, I am passionate about helping the UK’s strengths in bioscience innovation translate into commercial and investor success. I would bring my wide experience as an entrepreneur, creative thinker and communications professional to the Board, to help the BIA continue expanding its reach and impact, and in steering a successful future for UK biotech, as we navigate the unchartered waters of a post-Brexit environment and beyond.”

Sue been actively involved with the biotech sector for her entire career, since the mid-eighties, which was an exciting time when molecular biology was starting to drive a new industry. She gained a First Class degree in Biochemistry from Oxford, followed by PhD research at Leicester. Her passion for the emerging biotech sector led her into PR consultancy, working with many pioneering companies.

After gaining an MBA from Cranfield Business School, she founded De Facto, the UK’s first dedicated life sciences communications consultancy. Notable clients included the DTI’s £13m Biotech Means Business initiative and the global media launch of Dolly the Sheep. After a period working with venture capital companies and as an interim CEO of a biotech spin-out she founded Northbank Communications steering it through growth and M&A to become the global life sciences practice of College Hill (now re-branded as Instinctif Partners).

Her global experience spans advising early stage private to large multinational companies, seeing clients through periods of celebration and challenge, and supporting successful financings both privately and on public markets. She has also provided communications counsel to academic and not-for-profit organisations as well as numerous venture funds. She has contributed to initiatives to encourage the development of talent including as a supporter of BiotechYES and as founder of the ‘Career Alternatives for Scientists’ initiative. She was named as one of most inspirational women working in Life Sciences in the 50 Movers & Shakers in BioBusiness 2016 report.

Read about Sue’s passion for the sector and drive to support celebration of success HERE and her insights following the Life Sciences Industry Strategy report HERE

Notes to Editors

Instinctif Partners
Instinctif Partners is a leading international business communications consultancy and has recently been awarded International Agency of the Year at the PR Week Global Awards 2017. The firm has an exceptionally strong dedicated team focused in the Life Sciences sector. This Life Sciences practice has expertise across financial, corporate, healthcare and marketing communications, and integrates design and digital into its communications mix. Offering global outreach, its client base spans pharma, biotechnology, medical devices, diagnostics, healthcare, laboratory supply and service providers in addition to venture capitalists, recruitment companies, not-for-profit, academic organisations and science-associated bodies.

For Further Information:
Sue Charles
Managing Partner, Life Sciences
+44 (0)20 7457 2020

back to news